Since our report of emergence of a plasmid-mediated colistin resistance mechanism involving the *mcr-1* gene in *Escherichia coli* ([@R1]), *mcr-1* has been found in \>30 countries in 5 continents in \<1 year ([@R2]). *E. coli* is the main host of *mcr-1*, although several other *Enterobacteriaceae*, including *Salmonella*, have also been implicated as carriers of this gene ([@R3]*,*[@R4]). We screened pigs at slaughter for *Salmonella* isolates to elucidate the epidemiology of *mcr-1* in this major foodborne pathogen, which a serious public health problem.

The Study
=========

During July 2013--May 2014, a total of 1,780 cecum samples were obtained from pigs at 5 slaughter houses in southern and central China. Samples were incubated in buffered peptone water for 20 h and then inoculated into chromogenic medium selective for *Salmonella* spp. (CHROMagar Microbiology, Paris, France) for 24 h. Suspected *Salmonella* colonies were selected (1 isolate was selected from each sample) and identified by using PCR for detection of the *invA* gene.

We obtained 142 *Salmonella* isolates and screened them for *mcr-1* by using PCR and sequencing with primers described ([@R1]); 21 (14.8%) were positive for *mcr-1*. These isolates were serotyped as described ([@R5]). We determined the clonal relationship of *mcr-1*--positive isolates by using pulsed-field gel electrophoresis (PFGE) with *Xbal*I restriction enzyme and identified sequence types (STs) of these isolates by using multilocus sequence typing (<http://mlst.warwick.ac.uk/mlst/dbs/Senterica>).

Most of the isolates had indistinguishable PFGE patterns and were clonally related to serovar Typhimurium ST34 (n = 19), which was the dominant type ([Table](#T1){ref-type="table"}). ST34 is common in isolates from humans in China and other countries and has been linked to food-producing animals ([@R6]*,*[@R7]).

###### Characteristics of *mcr-1*--positive *Salmonella* isolates from pigs at slaughter, China, 2013--2014\*

  Strain     Serovar       PFGE type   Sequence type   S1-PFGE, plasmid, kb   Colistin MIC, mg/L   Polymyxin B MIC, mg/L   Other antimicrobial drug resistance†   Resistance gene‡
  ---------- ------------- ----------- --------------- ---------------------- -------------------- ----------------------- -------------------------------------- ---------------------
  SH149      Typhimurium   A5          34              ≈180                   2                    4                       AMP, STR, GEN, FFC, SXT, TET           *floR*, *oqxAB*
  SH143      Typhimurium   A1          34              ≈180                   2                    4                       AMP, STR, GEN, FFC, SXT, TET           *floR*, *oqxAB*
  SH138      Typhimurium   A1          34              ≈180                   2                    4                       AMP, STR, GEN, FFC, SXT, TET           *floR*, *oqxAB*
  SH93       Typhimurium   A1          34              ≈180                   2                    8                       FFC, SXT, TET                          *floR*, *oqxAB*
  SH33       Typhimurium   A1          34              ≈110                   2                    4                       AMP, STR, SXT, TET                     *oqxAB*
  SH137      Typhimurium   A1          34              ≈180                   2                    8                       AMP, STR, GEN, FFC, SXT, TET           *floR*, *oqxAB*
  SA316      Typhimurium   A1          34              ≈180                   2                    8                       AMP, STR, GEN, FFC, SXT, TET           *floR*
  SH127      Typhimurium   A1          34              ≈180                   2                    4                       AMP, STR, GEN, FFC, SXT, TET           *floR*, *oqxAB*
  SH128      Typhimurium   A1          34              ≈180                   2                    4                       AMP, STR, GEN, FFC, SXT, TET           *floR*, *oqxAB*
  SH133      Typhimurium   A1          34              ≈180                   2                    4                       AMP, STR, GEN, FFC, SXT, TET           *floR*, *oqxAB*
  SH134      Typhimurium   A1          34              ≈180                   2                    4                       AMP, STR, GEN, FFC, SXT, TET           *floR*, *oqxAB*
  SH17       Typhimurium   A1          34              ≈180                   2                    4                       AMP, STR, GEN, FFC, SXT, TET           *floR*, *oqxAB*
  SH239      Typhimurium   A1          34              ≈180, ≈138             2                    8                       AMP, STR, GEN, FFC, SXT, TET           *floR*
  SH271      Typhimurium   A1          34              ≈180                   2                    8                       AMP, STR, GEN, FFC, SXT, TET           *floR*, *oqxAB*
  SH83       Typhimurium   A1          34              ≈180                   2                    4                       AMP, STR, GEN, FFC, SXT, TET           *floR*, *oqxAB*
  SH205      Typhimurium   A1          34              ≈180                   2                    8                       AMP, STR, GEN, FFC, SXT, TET           *floR*, *oqxAB*
  SH39       Typhimurium   A2          34              ≈180                   2                    4                       AMP, STR, GEN, FFC, SXT, TET           *floR*, *oqxAB*
  SH178      Typhimurium   A1          34              ≈180                   2                    4                       AMP, STR, GEN, FFC, SXT, TET           *floR*, *oqxAB*
  SH175§     Typhimurium   A4          34              ≈180                   2                    8                       AMP, STR, GEN, **FFC,** SXT, TET       ***floR*, *oqxAB***
  SH36§      Heidelberg    B           ND              ≈180                   2                    8                       STR, **FFC**, SXT                      ***floR*, *oqxAB***
  Z4P319S§   London        C           ND              ≈180                   1                    2                       AMP, STR, GEN, **FFC**,CIP, SXT, TET   ***floR*, *oqxAB***

\*According to recommendations of the joint Clinical and Laboratory Standards Institute (CLSI)--European Committee on Antimicrobial Susceptibility Testing (EUCAST) and the Polymyxin Breakpoints Working Group (<http://www.eucast.org/>), the International Organization for Standardization standard broth microdilution method (20776--1) was used to determine colistin MICs for these strains. Antimicrobial susceptibility was determined and evaluated according to CLSI document no. M100-S25 (<http://shop.clsi.org/site/Sample_pdf/M100S25_sample.pdf>). Resistance to florfenicol was interpreted according to EUCAST clinical breakpoints and epidemiological cutoff values (\>16 mg/L) (<http://mic.eucast.org/Eucast2/>). MICs of olaquindox for all isolates, except SH36, were [\>]{.ul}64 mg/L. AMP, ampicillin; CIP, ciprofloxacin; FFC, florfenicol; GEN, gentamicin; ND, not determined; STR, streptomycin; SXT, sulfamethoxazole/trimethoprim; TET, tetracycline. †Boldface indicates resistance phenotypes transferred to a recipient by transformation. ‡Boldface indicates resistance genes transferred to a recipient by transformation. §Original strains of transformants.

We determined MICs for 12 antimicrobial drugs for all *mcr-1--*positive isolates by using agar dilution methods or a broth microdilution method. Colistin showed MICs of 1--2 mg/L for these isolates ([Table](#T1){ref-type="table"}). More than 80% of the isolates were also resistant to ampicillin, streptomycin, florfenicol, tetracycline, sulfamethoxazole/trimethoprim, and gentamicin; 76.2% showed reduced susceptibility (MIC \>0.06 mg/L) to ciprofloxacin.

We identified 2 lipopolysaccharide regulatory genes (*pmrA* and *pmrB*) by using and PCR and sequencing ([@R8]). Plasmid-mediated resistance genes *floR* (florfenicol resistance) and *oqxAB* (olaquindox and ciprofloxacin resistance) were detected by using PCR. None of the 21 isolates had mutations in the *pmrA* and *pmrB* genes, which are associated with colistin resistance in *Salmonella* isolates. A total of 20 and 19 isolates had the *floR* and *oqxAB* genes, respectively. *Salmonella* Typhimurium ST34 has also been associated with the spread of the *oqxAB* gene in human clinical isolates in China ([@R9]), and *Salmonella* Typhimurium ST34 coproducing *oqxAB* or *floR* genes has also been isolated from humans in Europe and Canada ([@R4]*,*[@R10]).

To determine the genetic context of *mcr-1*, we used PCR mapping with primers ISAP-F (5′-CGAAGCACCAAGACATCA-3′) and MCR-R (5′-CCACAAGAACAAA CGGACT-3′). Insertion sequence IS*Apl1* was found upstream of *mcr-1* for all isolates.

We determined transferability and location of *mcr-1* by using conjugation, transformation, and hybridization (with S1-PFGE nuclease). These procedures showed that *mcr-1* genes were located on an ≈180-kb plasmid, except for those in strains SH33 (≈110-kb plasmid) and SH239 (≈180-kb plasmid and ≈138-kb plasmid) ([Table](#T1){ref-type="table"}). However, the *mcr-1* gene could not be transferred to *E. coli* C600 by conjugation.

We then randomly selected 6 *mcr-1*--positive *Salmonella* isolates (SH138, SH149, SH175, SH36, SH39, and Z4P319S) for chemical transformation, which was successful for SH175, SH36, and Z4P319S. S1-PFGE confirmed that transformants harbored single plasmids and had 8--16-fold higher MICs for colistin than the recipient *E. coli* DH5α. The *floR* and *oqxAB* genes were also transferred with the *mcr-1* gene.

We used Hiseq Technology (Illumina, San Diego, CA, USA) to sequence plasmid DNA purified from transformants of *Salmonella* Heidelberg SH36 and *Salmonella* London Z4P319S and genomic DNA extracted from the original isolate (*Salmonella* Typhimurium SH138, which was selected as a representative ST34 strain). We assembled sequence reads were assembled into contigs by using SOAPdenovo version 2.04 (<http://soap.genomics.org.cn/soapdenovo.html>) and the separated plasmid contigs of the 3 *mcr-1*--carrying plasmids from chromosomal contigs and compared them with pHNSHP45--2 by using blastn (<http://blast.ncbi.nlm.nih.gov/Blast.cgi>) and BRIG ([@R11]). We then analyzed replicon sequence types of these plasmids by using the Plasmid MLST Database (<http://pubmlst.org/plasmid/>) and performed analysis and annotation of the partial sequence of *mcr-1*--carrying plasmids by using the RAST Server ([@R12]), ISfinder ([https://www-is.biotoul.fr](https://www-is.biotoul.fr//)), BLAST (<http://blast.ncbi.nlm.nih.gov/Blast.cgi>), and Gene Construction Kit 4.0 (Textco BioSoftware, Inc., West Lebanon, NH, USA).

For the 3 isolates, we found *mcr-1* on derivatives of IncHI2-like plasmids, which also harbored IncF (F4) and IncFIB (B53) replicons. The 3 plasmids were named pHNSH36 (from strain SH36), pHNZ319S (from strain Z4P319S), and pHNSH138 (from strain SH138). IncHI2 plasmids, such as pHNSHP45--2, have been frequently associated with global spread of *mcr-1* genes ([@R3]*,*[@R13]*,*[@R14]).

Compared with pHNSHP45--2 (in *E. coli* isolated from a pig in China \[[@R14]\]), the 3 plasmids all had a typical IncHI2-type backbone coding replication, transfer, maintenance, and stability functions, and a multiresistance region. However, we did not identify conjugative transfer region 1 of IncHI2 plasmids, including *traJGIH* and *trhRYXFHG*, in the 3 plasmids ([Figure 1](#F1){ref-type="fig"}, panel A), which might be the reason why these plasmids were not transferred by conjugation.

![Sequence comparison of scaffolds (portions of genome sequences reconstructed from end-sequenced whole-genome clones) identified in *mcr-1*--positive plasmids pHNSH36, pHNZ319S, and pHNSH138 with 2 *mcr-1*--bearing plasmids pHNSHP45-2 (GenBank accession no. KU341381) and pMR0516mcr (GenBank accession no. KX276657), and contigs identified in *mcr-1*--positive genomes of *Escherichia coli* strain NT1 in BRIG ([@R11]) (GenBank accession LSBW01000090.1) obtained during analysis of *mcr-1*--positive *Salmonella* isolates from pigs at slaughter, China, 2013--2014. Arrows indicate positions and direction of transcription of genes. Reference plasmids pHNSHP45--2 (A) and pMR0516mcr (B) are indicated in black in the outer circles.](16-1543-F1){#F1}

The multiresistance region contained numerous resistance genes, such as *oqxAB*, *floR*, *sul1*, *cmlA*, *aadA2*, and complete or truncated insertion sequences and transposons (IS*26*, ΔTn*2*, Tn*21*, IS*1006*, and IS*CR2*), which was similar to that of pHNSHP45-2, except that pHNSH36, pHNZ319S, and pHNSH138 were missing *fosA3* and *bla*~CTX-M-14~ ([Figure 1](#F1){ref-type="fig"}, panel A). The 2,635-bp module (*mcr-1*-ΔIS*Apl1*) was similar to that of pHNSHP45-2, but different in some aspects, such as insertion sites and orientation, which were identical to those of the novel IncHI2-IncF plasmid pMR0516mcr (GenBank accession no. KX276657) found in a clinical *E. coli* isolate from the United States ([@R15]), and human *E. coli* strain TN1 from Vietnam (GenBank accession no. LSBW01000090.1) ([Figure 2](#F2){ref-type="fig"}).

![Genetic organization of scaffolds (portions of genome sequences reconstructed from end-sequenced whole-genome clones) containing *mcr-1* harbored by plasmids pHNSH36, pHNZ319S, and pHNSH138 obtained during analysis of *mcr-1*--positive *Salmonella* isolates from pigs at slaughter, China, 2013--2014, and structural comparison with plasmids pHNSHP45--2, pMR0516mcr, and *Escherichia coli* TN1 contig 18. Arrows indicate positions and direction of transcription of genes. Regions with \>99% homology are indicated in gray or blue. Triangles indicate truncated genes. Information in parentheses after isolates indicate source, location, and GenBank accession number.](16-1543-F2){#F2}

Similar to pMR0516mcr (IncHI2-F18:A-:B1) ([Figure 1](#F1){ref-type="fig"}, panel B), the 3 plasmids also contained an IncF-type backbone, including regions coding replication and partial regions coding transfer, maintenance, and stability functions. Similar to pHNSHP45-2, the plasmid carrying *mcr-1* in strain NT1 belonged to the ST3-IncHI2 plasmid group. However, pMR0516mcr and the 3 plasmids described in this study were not typeable because there were no smr0199 loci in the IncHI2 plasmid ([Figure 1](#F1){ref-type="fig"}, panel B). These data suggest that the *mcr-1*-IS*Apl1* module might have first been inserted into IncHI2 plasmids and that recombination between IncF- and IncHI2-type plasmids might have occurred subsequently, resulting in acquisition of the IncF-backbone fragment and deletion of the IncHI2 transfer region 1 or combination with the replication region in some instances.

Conclusions
===========

We found that spread of *mcr-1* in pigs at slaughter in China was associated with clonal dissemination of *Salmonella* Typhimurium ST34. This organism has also been detected in Portugal and England ([@R3]*,*[@R4]). The presence of indistinguishable IncHI2-F4:A-:B5 plasmids in different *Salmonella* serovars indicates that horizontal transfer of *mcr-1--*harboring plasmids might have also contributed to spread of *mcr-1* in *Salmonella* spp.

Other drug-resistance genes, such as *floR* and *oqxAB*, were always transferred with *mcr-1* by IncHI2-F4:A-:B5 plasmids, which led to successful flow of *mcr-1*--harboring *Salmonella* isolates under various selective pressures because florfenicol and olaquindox are widely used in farm animals in China. In addition, spread of similar IncHI2-like plasmids and *Salmonella* Typhimurium ST34 clones carrying *mcr-1* in different countries highlights the need for internationally coordinated intervention strategies to limit its further dissemination.
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